NCT04538872: StraDiMS

Learning Strategies for Improving Dual Task Performance in Multiple Sclerosis

Completed NA Last updated 2 September 2021

What this trial tests

NA trial testing StraDiMS implicit in Multiple Sclerosis in 37 participants. Completed in 30 April 2021.

Timeline

1 September 2020

Primary endpoint
30 April 2021

30 April 2021

Quick facts

Lead sponsor	Hasselt University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	other
Enrollment	37
Start date	1 September 2020
Primary completion	30 April 2021
Estimated completion	30 April 2021
Sites	2 locations across Belgium

Drugs / interventions tested

• StraDiMS implicit
• StraDiMs explicit

Conditions studied

• Multiple Sclerosis — all drugs for Multiple Sclerosis →

Sponsor

Hasselt University

Who can join

Adults 18 to 65, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a randomized controlled study in which we aim to include 60 persons with Multiple Sclerosis and 30 healthy controls. Two different learning strategies, an explicit and an implicit one, will be compared on effects on dual task performance. Further, clinical profile associated with these effects, and brain activity measured by functional near-infrared spectroscopy during dual tasking will be investigated.

To this end, the study will cover 4 days:

Day 1: examine clinical profile; Day 2: baseline dual task measures; Day 3: experimental learning paradigm with subjects randomly assigned to either the implicit or the explicit learning condition.

Day 4: delayed retention dual task and fNIRS measures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.